Pfizer: Undervalued with high dividends but facing challenges. Explore why sentiment remains weak and if downward trends persist.

Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...

As President Donald Trump hits 100 days in his second term, the administration is touting the billions of investments companies such as Apple and Merck are making in the United States ...

Shares of Hims & Hers Health (NYSE:HIMS) climbed ~34% in the premarket on Tuesday after the telehealth company announced a ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

(Reuters) -Danish drugmaker Novo Nordisk has partnered with Hims & Hers Health's to sell its popular weight loss drug through ...

Merck & Co. will grow its U.S. manufacturing footprint with a $1 billion plant in Delaware, becoming the latest drugmaker to ...

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

AstraZeneca has axed three MedImmune legacy monoclonal antibody drugs from its neuroscience pipeline in a first-quarter clear ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...

Pfizer ( PFE) reported mixed first quarter earnings Tuesday, as the company struggles to gain investor interest in its ...